Form 8-K - Current report:
SEC Accession No. 0001104659-24-119756
Filing Date
2024-11-15
Accepted
2024-11-15 16:50:12
Documents
13
Period of Report
2024-11-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428644d1_8k.htm   iXBRL 8-K 27205
  Complete submission text file 0001104659-24-119756.txt   199645

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbio-20241112.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20241112_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20241112_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2428644d1_8k_htm.xml XML 3565
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 241468631
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)